We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
-0.05%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$17.5B
AUM Growth
-$4.53B
(-21%)
Cap. Flow
-$3.73B
Cap. Flow
% of AUM
-21.26%
Top 10 Holdings %
Top 10 Hldgs %
49.23%
Holding
203
New
48
Increased
29
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$292M |
| 2 |
KKR & Co
KKR
|
+$280M |
| 3 |
Roivant Sciences
ROIV
|
+$248M |
| 4 |
Mastercard
MA
|
+$138M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$650M |
| 2 |
CYBR
CyberArk
CYBR
|
+$470M |
| 3 |
Salesforce
CRM
|
+$334M |
| 4 |
Nasdaq
NDAQ
|
+$290M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.56% |
| 2 | Financials | 12.21% |
| 3 | Technology | 11.18% |
| 4 | Consumer Discretionary | 5.09% |
| 5 | Industrials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Piper Sandler
PIPR
$5.16B
| $5.05M | 0.03% |
+66,000
| New | +$5.42M |
|
77
AAR Corp
AIR
$5.38B
| $5.04M | 0.03% |
+46,000
| New | +$4.95M |
|
78
Rio Tinto
RIO
$147B
| $5.02M | 0.03% |
+53,800
| New | +$4.9M |
|
79
Garrett Motion
GTX
$5.95B
| $5M | 0.03% |
+275,000
| New | +$5.13M |
|
80
Rollins
ROL
$21.7B
| $4.97M | 0.03% |
+93,000
| New | +$5.53M |
|
81
Affirm
AFRM
$25.5B
| $4.95M | 0.03% |
+108,000
| New | +$6.24M |
|
82
Inter&Co
INTR
$2.37B
| $4.89M | 0.03% |
+614,500
| New | +$5.33M |
|
83
Cummins
CMI
$89.5B
| $4.84M | 0.03% |
+9,000
| New | +$5.09M |
|
|
FISV
84
Fiserv Inc
FISV
$27B
| $4.8M | 0.03% |
+86,000
| New | +$5.32M |
|
85
Vertiv
VRT
$111B
| $4.76M | 0.03% |
+19,000
| New | +$4.22M |
|
86
Amkor Technology
AMKR
$15.6B
| $4.68M | 0.03% |
104,000
-360,000
| -78% | -$17.2M |
|
|
RNA
87
Atrium Therapeutics
RNA
$208M
| $4.67M | 0.03% |
+349,360
| New | +$4.91M |
|
88
GlobalFoundries
GFS
$31.5B
| $4.67M | 0.03% |
+105,000
| New | +$4.63M |
|
89
Molina Healthcare
MOH
$11.7B
| $4.67M | 0.03% |
+35,000
| New | +$5.57M |
|
|
IRD
90
Opus Genetics
IRD
$270M
| $4.55M | 0.03% |
+1,000,000
| New | +$3.46M |
|
91
Tenable Holdings
TENB
$4.4B
| $4.48M | 0.03% |
+265,000
| New | +$5.56M |
|
92
Prime Medicine
PRME
$565M
| $4.32M | 0.02% |
1,240,843
| – | – |
|
93
ServiceNow
NOW
$106B
| $4.29M | 0.02% |
+41,000
| New | +$4.82M |
|
|
SMC
94
Summit Midstream
SMC
$407M
| $1.76M | 0.01% |
58,214
| – | – |
|
95
Madrigal Pharmaceuticals
MDGL
$12.8B
| $1.74M | 0.01% |
3,319
| – | – |
|
96
Capricor Therapeutics
CAPR
$1.13B
| $1.25M | 0.01% |
41,000
| – | – |
|
97
Arrowhead Research
ARWR
$10.5B
| $991K | 0.01% |
15,800
| – | – |
|
|
ANNAW
98
AleAnna Inc Warrant
ANNAW
$12.5M
| $802K | ﹤0.01% |
990,000
| – | – |
|
99
Guardant Health
GH
$20.7B
| $739K | ﹤0.01% |
8,000
-101,000
| -93% | -$10.1M |
|
100
Alkermes
ALKS
$8.79B
| $735K | ﹤0.01% |
20,800
| – | – |
|
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
Farallon Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Farallon Capital Management held 203 positions worth $17.5B, down 21% from $22.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Farallon Capital Management withdrew a net $3.73B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 43% a quarter earlier, followed by Financials and Technology.
Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.
- Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
- Farallon Capital Management added most to Broadcom in Q1 2026, an estimated $292M increase.
- Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
- Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
- Farallon Capital Management's ten largest holdings make up 49% of its $17.5B portfolio in Q1 2026.
- Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
- Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $17.5B.
Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.